Cancer Research

In today's world, humans are at the top of the food chain. We have almost no natural predators as there are few animals that rely on humans as prey. Pathogens are the only exception. Viruses, bacteria, parasites and other classes of infectious agents ...

Blog Post - Erin Richards - Nov 17 2008 - 12:15pm

Merck Serono Announces One-Month Results Of Pharmacogenomics Study PREDICT At 47th Annual Meeting Of The European Society For Pa

GENEVA, Switzerland, September 23 /PRNewswire/--- PREDICT Aims to Identify Potential Genetic Markers and Additional Serum Biomarkers That Could Play a Role in Predicting the Response to Growth Hormone Treatment in Children With Growth Hormone Deficiency o ...

Article - Anna Ohlden - Sep 23 2008 - 7:31am

CISBIO Bioassays Launches Chromoa(TM) Chromogranin A ELISA Kit

BAGNOLS-SUR-CÈZE, France, September 23 /PRNewswire/--- Company's Expertise in Chromogranin A Tumor Detection Marker Technology Now Applied to Universal Technique CISBIO Bioassays, a member of IBA group and a developer and marketer of diagnostic assay ...

Article - Anna Ohlden - Sep 23 2008 - 11:31am

Nice Approves Pradaxa(R)*(Dabigatran Etexilate)- First New Oral Anticoagulant In The UK For Over 50 Years

...

Article - Anna Ohlden - Sep 24 2008 - 2:32am

Rosetta Genomics To Present At Maxim Group Growth Conference

REHOVOT, Israel and JERSEY CITY, New Jersey, September 24 /PRNewswire/-- Rosetta Genomics Ltd (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics, announced today its management will present at the Maxim Group Growth Conference in New ...

Article - Anna Ohlden - Sep 24 2008 - 7:31am

Bioinformatics Breakthrough- Complete Annotation Of Human Proteins

Professor Ron Appel, speaking at the 10th anniversary conference of the Swiss Institute of Bioinformatics in Berne, Switzerland, says they have completed the annotation of human proteins. Where the Human Genome Project produced a dictionary, this new work ...

Article - News Staff - Sep 24 2008 - 10:07am

Merck Serono's Kuvan(R) Recommended For European Approval

GENEVA, Switzerland, September 26 /PRNewswire/--- CHMP Issued Positive Opinion Recommending Marketing Authorization of Kuvan(R) for the Treatment of hyperphenylalaninemia in Patients With phenylketonuria or BH4 Deficiency ...

Article - Anna Ohlden - Sep 26 2008 - 2:33am

Stopping Cancer Drug Resistance At The Source

We have many great anti-tumor drugs that can do a fantastic job destroying the molecular insides of tumor cells. There is, however, a major catch: tumors have a nasty habit of become drug resistant. Such is the case with the breast cancer chemotherapeutic ...

Article - Michael White - Sep 27 2008 - 11:55am

PNPLA3 Gene Variants Boosts Risks Of Fatty Liver Disease

Researchers at UT Southwestern Medical Center have found that individuals who carry a specific form of the gene PNPLA3 have more fat in their livers and a greater risk of developing liver inflammation. They also found that Hispanics are more likely to carr ...

Article - News Staff - Sep 28 2008 - 10:15am

Beta-catenin May Be 'Hub' For Fear In Mammals

A protein required for the earliest steps in embryonic development also plays a key role in solidifying fear memories in the brains of adult animals, scientists have revealed. An apparent "hub" for changes in the connections between brain cells, ...

Article - News Staff - Sep 28 2008 - 1:34pm